Cargando…

Enhancing the antibacterial activity of polymyxins using a nonantibiotic drug

Purpose: The rapid emergence of multidrug-resistant (MDR) bacteria and the lack of new therapies to eliminate them poses a major threat to global health. With the alarming rise in antimicrobial resistance (AMR), focus has now shifted to the use of the polymyxin class of antibiotics as the last line...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krishnamurthy, Malathy, Lemmon, Margaret M, Falcinelli, Evan M, Sandy, Reuel A, Dootz, Jennifer N, Mott, Tiffany M, Rajamani, Sathish, Schaecher, Kurt E, Duplantier, Allen J, Panchal, Rekha G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555264/ https://www.ncbi.nlm.nih.gov/pubmed/31239720 http://dx.doi.org/10.2147/IDR.S196874

Ejemplares similares

Bacterial genome engineering and synthetic biology: combating pathogens
por: Krishnamurthy, Malathy, et al.
Publicado: (2016)

Nonantibiotic Effects of Fluoroquinolones in Mammalian Cells
por: Badal, Sujan, et al.
Publicado: (2015)

Immunotherapy of Autoimmune Diseases with Nonantibiotic Properties of Tetracyclines
por: Park, Chan-Su, et al.
Publicado: (2020)

Using Selection by Nonantibiotic Stressors to Sensitize Bacteria to Antibiotics
por: Maltas, Jeff, et al.
Publicado: (2020)

Mitigating the Impact of Antibacterial Drug Resistance through Host-Directed Therapies: Current Progress, Outlook, and Challenges
por: Chiang, Chih-Yuan, et al.
Publicado: (2018)

Antibiotic Resistance in Staphylococcus aureus Strains Isolated from Cows with Mastitis in Eastern Poland and Analysis of Susceptibility of Resistant Strains to Alternative Nonantibiotic Agents: Lysostaphin, Nisin and Polymyxin B
por: SZWEDA, Piotr, et al.
Publicado: (2013)

Antibacterial Mechanisms of Polymyxin and Bacterial Resistance
por: Yu, Zhiliang, et al.
Publicado: (2015)

An oldie but a goodie: Methenamine as a nonantibiotic solution to the prevention of recurrent urinary tract infections
por: Gu, Cindy, et al.
Publicado: (2023)

Clinical Application of Development of Nonantibiotic Macrolides That Correct Inflammation-Driven Immune Dysfunction in Inflammatory Skin Diseases
por: Rodriguez-Cerdeira, Carmen, et al.
Publicado: (2012)

Polymyxin Stereochemistry and Its Role in Antibacterial Activity and Outer Membrane Disruption
por: Slingerland, Cornelis J., et al.
Publicado: (2022)

Mathematical Model of the Impact of a Nonantibiotic Treatment for Clostridium difficile on the Endemic Prevalence of Vancomycin-Resistant Enterococci in a Hospital Setting
por: Grima, Daniel T., et al.
Publicado: (2012)

Synergistic Membrane Disturbance Improves the Antibacterial Performance of Polymyxin B
por: Li, Wenwen, et al.
Publicado: (2022)

The Nonantibiotic Small Molecule Cyslabdan Enhances the Potency of β-Lactams against MRSA by Inhibiting Pentaglycine Interpeptide Bridge Synthesis
por: Koyama, Nobuhiro, et al.
Publicado: (2012)

A Novel Nonantibiotic, lgt-Based Selection System for Stable Maintenance of Expression Vectors in Escherichia coli and Vibrio cholerae
por: Terrinoni, Manuela, et al.
Publicado: (2018)

Biodegradable nanocarriers coated with polymyxin B: Evaluation of leishmanicidal and antibacterial potential
por: Souza Ribeiro Costa, Juliana, et al.
Publicado: (2019)

Polymyxins and Bacterial Membranes: A Review of Antibacterial Activity and Mechanisms of Resistance
por: Ayoub Moubareck, Carole
Publicado: (2020)

Combating biothreat pathogens: ongoing efforts for countermeasure development and unique challenges
por: Duplantier, Allen J., et al.
Publicado: (2020)

Effects of nonantibiotic growth promoter combinations on growth performance, nutrient utilization, digestive enzymes, intestinal morphology, and cecal microflora of broilers
por: Li, Zunyan, et al.
Publicado: (2023)

Acute Cystitis Symptom Score questionnaire for measuring patient-reported outcomes in women with acute uncomplicated cystitis: Clinical validation as part of a phase III trial comparing antibiotic and nonantibiotic therapy
por: Alidjanov, Jakhongir F., et al.
Publicado: (2020)

Aminomethyl spectinomycins: a novel antibacterial chemotype for biothreat pathogens
por: Scarff, Jennifer M., et al.
Publicado: (2019)

Postoperative Prevention of Urinary Tract Infections in Patients after Urogynecological Surgeries—Nonantibiotic Herbal (Canephron) versus Antibiotic Prophylaxis (Fosfomycin Trometamol): A Parallel-Group, Randomized, Noninferiority Experimental Trial
por: Wawrysiuk, Sara, et al.
Publicado: (2022)

Antibacterial Activity of Rhizome of Curcuma aromatica and Partial Purification of Active Compounds
por: Revathi, S., et al.
Publicado: (2013)

Bioengineering of bacterial pathogens for noninvasive imaging and in vivo evaluation of therapeutics
por: Rajamani, Sathish, et al.
Publicado: (2018)

Ceftazidime/avibactam Improves the Antibacterial Efficacy of Polymyxin B Against Polymyxin B Heteroresistant KPC-2-Producing Klebsiella pneumoniae and Hinders Emergence of Resistant Subpopulation in vitro
por: Ma, Xingyan, et al.
Publicado: (2019)

The Difference Between Polymyxin B and Polymyxin E in Causing Skin Hyerpigmentation
por: Zou, Dongna, et al.
Publicado: (2021)

Difficulty in detecting low levels of polymyxin resistance in clinical Klebsiella pneumoniae isolates: evaluation of Rapid Polymyxin NP test, Colispot Test and SuperPolymyxin medium
por: Conceição-Neto, O.C., et al.
Publicado: (2020)

Polymyxins: To Combine or Not to Combine?
por: Perez, Federico, et al.
Publicado: (2019)

In vitro antibacterial activity of combinations of fosfomycin, minocycline and polymyxin B on pan-drug-resistant Acinetobacter baumannii
por: ZHANG, YAJUN, et al.
Publicado: (2013)

The antibacterial activity of peptide dendrimers and polymyxin B increases sharply above pH 7.4
por: Cai, Xingguang, et al.
Publicado: (2021)

Polymyxins facilitate entry into mammalian cells
por: Hamill, Kristina M., et al.
Publicado: (2016)

Antibacterial activity of Cinnamomum cassia L. essential oil in a carbapenem- and polymyxin-resistant Klebsiella aerogenes strain
por: Vasconcelos, Nathalie Gaebler, et al.
Publicado: (2020)

Discerning the role of polymyxin B nonapeptide in restoring the antibacterial activity of azithromycin against antibiotic-resistant Escherichia coli
por: Al-Marzooq, Farah, et al.
Publicado: (2022)

Overview of polymyxin resistance in Enterobacteriaceae
por: da Silva, Kesia Esther, et al.
Publicado: (2022)

Polymyxin B Etest Fails to Distinguish Carbapenem-resistant Enterobacteriaceae with Elevated Polymyxin B MICs
por: Kulengowski, Brandon, et al.
Publicado: (2017)

RapidResa Polymyxin Acinetobacter NP(®) Test for Rapid Detection of Polymyxin Resistance in Acinetobacter baumannii
por: Bouvier, Maxime, et al.
Publicado: (2021)

A Review of the Clinical Pharmacokinetics of Polymyxin B
por: Avedissian, Sean N., et al.
Publicado: (2019)

Transcriptional responses of Burkholderia cenocepacia to polymyxin B in isogenic strains with diverse polymyxin B resistance phenotypes
por: Loutet, Slade A, et al.
Publicado: (2011)

Purification, Characterization and in vitro Evaluation of Polymyxin A From Paenibacillus dendritiformis: An Underexplored Member of the Polymyxin Family
por: Jangra, Manoj, et al.
Publicado: (2018)

709. In Vitro Antibacterial Activity and In Vivo Efficacy of Sulbactam–Durlobactam (ETX2514SUL) Against Pathogenic Burkholderia Species
por: O’Donnell, John, et al.
Publicado: (2019)

Shifting Gears: The Future of Polymyxin Antibiotics
por: Lenhard, Justin R., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_74haptn14qb8n32i15frt6uvvc